Thomas F. Eleveld
Princess Máxima Center(NL)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Pluripotent Stem Cells Research, Cancer, Hypoxia, and Metabolism, Cell death mechanisms and regulation, CRISPR and Genetic Engineering
Most-Cited Works
- → Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations(2015)548 cited
- → RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma(2018)58 cited
- → Engineering large-scale chromosomal deletions by CRISPR-Cas9(2021)38 cited
- → Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors(2022)28 cited
- → The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors(2021)28 cited
- → Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q(2024)15 cited
- → Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers(2020)11 cited
- → MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma(2023)10 cited
- → Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma(2022)10 cited
- → Cytogenetic resource enables mechanistic resolution of changing trends in human pluripotent stem cell aberrations linked to feeder-free culture(2023)8 cited